Avecia Biotechnology

Avecia Biotechnology, operating as Avecia OligoMedicines, is an oligonucleotide contract manufacturing organization.

History:

Avecia Biotechnology was acquired by Nitto Denko in 2011. It is unclear if Avecio OligoMedicines will continute to operate as a separate business.

Acquisitions:
Boston BioSystems (1999)

Employment

Email:

Fax:

Mail:

General Info:

Ticker:

Employees:

Regions:
Europe

Research Focus:
Chemistry Instrumentation/Reagents Disease Therapeutics-Contract Manufacturing

 

Profiles:

 

News:

Keywords: 

Strategic Partnerships: